Top

11-07-2018 | Arthroplasty | Review | Article

Total Joint Arthroplasty in Patients with Inflammatory Rheumatic Diseases

Journal: Advances in Therapy

Authors: Riccardo Compagnoni, Roberta Gualtierotti, Pietro Randelli

Publisher: Springer Healthcare

Abstract

Since its introduction, total joint arthroplasty (TJA) has improved the quality of life of patients with degenerative joint disorders. In the last decades, a number of conventional and biological disease-modifying antirheumatic drugs have become available for the treatment of patients with inflammatory rheumatic diseases (IRD), leading to a reduction in the need to undergo TJA. However, TJA is still frequently performed in IRD patients. Both rheumatologists and orthopedics should be aware that patients with IRD have a peculiar perioperative risk profile due to disease-related, patient-related, and surgery-related risk factors. On the basis of current evidence, TJA is a safe procedure for IRD patients as long as an accurate risk stratification and a multidisciplinary approach are applied. We here describe the current strategies for an appropriate surgical management of osteoarthritis in IRD patients and the fascinating opening perspectives that surgeons and clinicians may expect in the future.

Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009;11(3):229.CrossRefPubMedPubMedCentral

Mertelsmann-Voss C, Lyman S, Pan TJ, Goodman S, Figgie MP, Mandl LA. Arthroplasty rates are increased among US patients with systemic lupus erythematosus: 1991–2005. J Rheumatol. 2014;41(5):867–74.CrossRefPubMed

Jamsen E, Virta LJ, Hakala M, Kauppi MJ, Malmivaara A, Lehto MU. The decline in joint replacement surgery in rheumatoid arthritis is associated with a concomitant increase in the intensity of anti-rheumatic therapy: a nationwide register-based study from 1995 through 2010. Acta Orthop. 2013;84(4):331–7.CrossRefPubMedPubMedCentral

Au K, Reed G, Curtis JR, et al. High disease activity is associated with an increased risk of infection in patients with rheumatoid arthritis. Ann Rheum Dis. 2011;70(5):785–91.CrossRefPubMed

Zhu Y, Zhang F, Chen W, Liu S, Zhang Q, Zhang Y. Risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis. J Hosp Infect. 2015;89(2):82–9.CrossRefPubMed

Gualtierotti R, Parisi M, Ingegnoli F. Perioperative management of patients with inflammatory rheumatic diseases undergoing major orthopaedic surgery: a practical overview. Adv Ther. 2018;35(4):439–56.CrossRefPubMedPubMedCentral

Pereira LC, Kerr J, Jolles BM. Intra-articular steroid injection for osteoarthritis of the hip prior to total hip arthroplasty: is it safe? A systematic review. Bone Jt J. 2016;98-B(8):1027–35.CrossRef

Gualtierotti R. Understanding cardiovascular risk in rheumatoid arthritis: still a long way to go. Atherosclerosis. 2017;256:123–4.CrossRefPubMed

Agca R, Heslinga SC, Rollefstad S, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017;76(1):17–28.CrossRefPubMed

10.

Trevisan C, Klumpp R, Compagnoni R. Risk factors in transient osteoporosis: a retrospective study on 23 cases. Clin Rheumatol. 2016;35(10):2517–22.CrossRefPubMed

11.

Eka A, Chen AF. Patient-related medical risk factors for periprosthetic joint infection of the hip and knee. Ann Transl Med. 2015;3(16):233.PubMedPubMedCentral

12.

Symmons DPM, Gabriel SE. Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol. 2011;7(7):399–408.CrossRefPubMed

13.

Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th edn: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(2 Suppl):e326S–e350S.CrossRefPubMedPubMedCentral

14.

Centola M, Cavet G, Shen Y, et al. Development of a multi-biomarker disease activity test for rheumatoid arthritis. PLoS One. 2013;8(4):e60635.CrossRefPubMedPubMedCentral

15.

Curtis JR, Xie F, Chen L, Saag KG, Yun H, Muntner P. Biomarker-related risk for myocardial infarction and serious infections in patients with rheumatoid arthritis: a population-based study. Ann Rheum Dis. 2018;77(3):386–92.CrossRefPubMed

16.

Munroe ME, Vista ES, Guthridge JM, Thompson LF, Merrill JT, James JA. Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare. Arthritis Rheumatol. 2014;66(7):1888–99.CrossRefPubMedPubMedCentral

17.

Zoller B, Li X, Sundquist J, Sundquist K. Autoimmune diseases and venous thromboembolism: a review of the literature. Am J Cardiovasc Dis. 2012;2(3 SRC—BaiduScholar):171–83.PubMedPubMedCentral

18.

Oberweis BS, Nukala S, Rosenberg A, et al. Thrombotic and bleeding complications after orthopedic surgery. Am Heart J. 2013;165(3):427–33.CrossRefPubMedPubMedCentral

19.

Trevisan C, Klumpp R, Auriemma L, Compagnoni R. An algorithm for predicting blood loss and transfusion risk after total hip arthroplasty. Transfus Apher Sci. 2018;57:272–6.CrossRefPubMed

20.

Goodman SM, Mackenzie CR. Cardiovascular risk in the rheumatic disease patient undergoing orthopedic surgery. Curr Rheumatol Rep. 2013;15(9):354.CrossRefPubMed

21.

de Laat B, Derksen RH, Urbanus RT, de Groot PG. IgG antibodies that recognize epitope Gly40–Arg43 in domain I of beta 2-glycoprotein I cause LAC, and their presence correlates strongly with thrombosis. Blood. 2005;105(4):1540–5.CrossRefPubMed

22.

de Laat B, Pengo V, Pabinger I, et al. The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost. 2009;7(11):1767–73.CrossRefPubMed

23.

Andreoli L, Nalli C, Motta M, et al. Anti-beta(2)-glycoprotein I IgG antibodies from 1-year-old healthy children born to mothers with systemic autoimmune diseases preferentially target domain 4/5: might it be the reason for their ‘innocent’ profile? Ann Rheum Dis. 2011;70(2):380–3.CrossRefPubMed

24.

Goodman SM, Springer B, Guyatt G, et al. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. Arthritis Rheumatol. 2017;69(8):1538–51.CrossRefPubMed

25.

Berbari EF, Osmon DR, Carr A, et al. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case–control study. Clin Infect Dis . 2010;50(1):8–16.CrossRefPubMed

26.

Correa JD, Calderaro DC, Ferreira GA, Mendonca SM, Fernandes GR, Xiao E. Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status. Microbiome. 2017;5(1 SRC—BaiduScholar):34.CrossRefPubMedPubMedCentral

27.

Bai M, Tomenson B, Creed F, et al. The role of psychological distress and personality variables in the disablement process in rheumatoid arthritis. Scand J Rheumatol. 2009;38(6):419–30.CrossRefPubMed

28.

Trevisan CL, Klumpp R, Recalcati W, Compagnoni R. Influence of personality psychology on outcome of total hip arthroplasty: a cross-sectional study on 69 patients. Musculoskelet Surg. 2015;99(3):231–6.CrossRefPubMed

29.

Syed Z, Rubinfeld I. Personalized risk stratification for adverse surgical outcomes: innovation at the boundaries of medicine and computation. Pers Med. 2010;7(6):695–701.CrossRef

30.

Ramiro S, Sepriano A, Chatzidionysiou K, et al. Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis. 2017;76(6):1101–36.CrossRefPubMed

31.

Nishida K, Harada R, Nasu Y, et al. The clinical course of patients with rheumatoid arthritis who underwent orthopaedic surgeries under disease control by tofacitinib. Mod Rheumatol. 2018:1–3. https://doi.org/10.1080/14397595.2018.1427431

32.

Grennan DM, Gray J, Loudon J, Fear S. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann Rheum Dis. 2001;60(3):214–7.CrossRefPubMedPubMedCentral

33.

Randelli P, Randelli F, Cabitza P, Vaienti L. The effects of COX-2 anti-inflammatory drugs on soft tissue healing: a review of the literature. J Biol Regul Homeost Agents. 2010;24(2):107–14.PubMed

34.

Mochizuki T, Yano K, Ikari K, et al. Tramadol hydrochloride/acetaminophen combination versus non-steroidal anti-inflammatory drug for the treatment of perioperative pain after total knee arthroplasty: a prospective, randomized, open-label clinical trial. J Orthop Sci. 2016;21(5):625–9.CrossRefPubMed

35.

Ting S, Schug S. The pharmacogenomics of pain management: prospects for personalized medicine. J Pain Res. 2016;9:49–56.PubMedPubMedCentral

36.

Behrooz A. Pharmacogenetics and anaesthetic drugs: implications for perioperative practice. Ann Med Surg (Lond). 2015;4(4):470–4.CrossRef

37.

Umicevic Mirkov M, Coenen MJ. Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine. Pharmacogenomics. 2013;14(4):425–44.CrossRefPubMed

38.

Nikiphorou E, Carpenter L, Morris S, et al. Hand and foot surgery rates in rheumatoid arthritis have declined from 1986 to 2011, but large-joint replacement rates remain unchanged: results from two UK inception cohorts. Arthritis Rheumatol. 2014;66(5):1081–9.CrossRefPubMed

39.

Jones CW, Jerabek SA. Current role of computer navigation in total knee arthroplasty. J Arthroplasty. 2018;33(7):1989–93.CrossRefPubMed

40.

Szczech B, McDermott JD, Issa K, et al. Patient-specific instrumentation in total knee arthroplasty: what is the evidence? J Knee Surg. 2016;29(4):341–5.CrossRefPubMed

41.

Christ AB, Pearle AD, Mayman DJ, Haas SB. Robotic-assisted unicompartmental knee arthroplasty: state-of-the art and review of the literature. J Arthroplasty. 2018;33(7):1994–2001.CrossRefPubMed

42.

Zhu S, Qian W, Jiang C, Ye C, Chen X. Enhanced recovery after surgery for hip and knee arthroplasty: a systematic review and meta-analysis. Postgrad Med J. 2017;93(1106):736–42.CrossRefPubMedPubMedCentral

43.

Mocsai A, Kovacs L, Gergely P. What is the future of targeted therapy in rheumatology: biologics or small molecules? BMC Med. 2014;12:43.CrossRefPubMedPubMedCentral

Medicine Matters Rheumatology

Abstract